Fortress Biotech FBIO 深 滬
已收盤 11-06 16:00:00 美东时间
1.85
+0.010
+0.54%
華盛通- 最 高1.87
- 今 開1.82
- 成交量 12.98万股
- 最 低 1.82
- 昨 收 1.84
- 總市值 6169.93万
- 52周最高 4.53
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.79
- 委 比 53.03%
- 總股本 3335.10万
- 歷史最高 190.50
- 量 比 0.70
- 振 幅 2.72%
- 歷史最低 1.24
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
Journey Medical Corporation will release its third quarter 2026 financial results after U.S. markets close on November 12, 2026. A conference call and audio webcast will be held at 4:30 p.m. ET on the same day to discuss the results and provide a corporate update. Interested parties can join the call by dialing 1-866-777-2509 (domestic) or 1-412-317-5413 (international), or register online via the provided link. A live webcast will also be availa...
11-05 13:30
Fortress Biotech Inc.收涨0.52%，成交额19.47万美元
11月4日，Fortress Biotech Inc.（FBIO）收涨0.52%，报1.94美元，成交额19.47万美元，市值6459.65万美元。 行情数据...
11-04 08:13
Fortress Biotech Inc.收涨3.21%，成交额30.12万美元
10月28日，Fortress Biotech Inc.（FBIO）收涨3.21%，报1.93美元，成交额30.12万美元，市值6436.7万美元。 行情数据...
10-28 07:17
Fortress Biotech Inc.收平，成交额46.87万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-20 07:22
Fortress Biotech Inc.收跌2.09%，成交额49.62万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:21
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Journey Medical Corporation (NASDAQ: DERM) announced that its CEO, Claude Maraoui, will attend two investor conferences in September 2026. The first is the Lake Street Capital Markets 10th Annual BIG10 Conference on September 10 in New York City, featuring 1x1 meetings. The second is the H.C. Wainwright 28th Annual Global Investment Conference on September 14, also in NYC, with a presentation and 1x1 meetings. A webcast of the H.C. Wainwright pre...
09-08 20:05
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
Longeveron Inc. appoints Nirav Jhaveri as Chief Financial Officer, bringing over 25 years of experience in biotech finance and capital markets. Jhaveri succeeds Marie Washburn, who returns to her role as Corporate Controller. The company highlights Jhaveri's expertise in advancing stem cell therapy, particularly its lead product laromestrocel, which is in Phase 2b trials for HLHS. Jhaveri aims to support the company's growth and operational effic...
08-19 20:05
Fortress Biotech Q2 Earnings Preview
Fortress Biotech (FBIO) is scheduled to announce Q2 earnings results on Wednesday, August 12th, after market close. The consensus EPS Estimate is -$0.20 and the consensus Revenue Estimate is $18.3M (+...
08-12 05:35
Fortress Biotech’s Urica Therapeutics Says Crystalys Closes Oversubscribed $130M Series B Financing To Support Late-Stage Global Clinical Development And Commercialization Preparation For Dotinurad
Urica Therapeutics, Inc. ("Urica" or the "Company"), a Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress") subsidiary, today announced that Crystalys Therapeutics, Inc. ("Crystalys"), in which Urica maintains an equity position, closed an oversubscribed $130 million Series B financing to support the l...
07-27 20:03
美股夜盘 | Namib Minerals涨69.74%，Replimune涨22.90%
Oculis Holding AG涨-33.98%；Fortress Biotech, Inc.涨-10.36%；Iris Acquisition Corp. II Class A涨-9.77%
06-01 08:05
